Jia Meng
Research Subjects
Jia Meng has a total of 36 co-authors. Here are the top co-authors by number of shared publications:
- Joe Yeong
The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang 325000, China
2 shared publications Bijin Veonice Au
Agency of Science
1 shared publicationBin Tean Teh
National Cancer Centre Singapore, Singapore, Republic of Singapore
1 shared publicationBo Li
Department of Blood Purification, The Second Hospital of Tianjin Medical University, Tianjin, China
1 shared publicationCedric Chuan Young Ng
National Cancer Centre Singapore, Singapore, Republic of Singapore
1 shared publication- Craig Ryan Cecil Joseph
Agency for Science, Technology and Research (A*STAR) 14 Integrated Central Operations and Research Enablers Singapore, Singapore
1 shared publication
Latest Publications
- Open Access
- 9 December 2024
- Published by American Association for the Advancement of Science (AAAS) in Cancer Communications
- Vol. 45 (2) , 172-177
The interplay between natural killer cells and pancreatic stellate cells in pancreatic ductal adenocarcinoma
- 9 December 2024
- Published by American Association for the Advancement of Science (AAAS) in Cancer Communications
- Vol. 45 (2) , 172-177
Open AccessThe interplay between natural killer cells and pancreatic stellate cells in pancreatic ductal adenocarcinoma
- 14 December 2023
- Published by Elsevier in Laboratory Investigation
- Vol. 104 (3) , 100303
The Prognostic Value of CD39 as a Marker of Tumor-Specific T Cells in Triple-Negative Breast Cancer in Asian Women
- 14 December 2023
- Published by Elsevier in Laboratory Investigation
- Vol. 104 (3) , 100303
The Prognostic Value of CD39 as a Marker of Tumor-Specific T Cells in Triple-Negative Breast Cancer in Asian Women
- 10 February 2022
- Published by Springer Nature in International Urology and Nephrology
- Vol. 54 (9) , 2343-2354
Exosomal circTAOK1 contributes to diabetic kidney disease progression through regulating SMAD3 expression by sponging miR-520h
Background Diabetic nephropathy (DN) is a frequent diabetes complication with complex pathogenesis. Circular RNA (circRNA) circTAOK1 (also named circ_0003928) has been reported to be upregulated in high glucose (HG)-treated human umbilical vein endothelial cells. Also, exosomal circRNAs can exert significant roles in the pathology of various diseases. This study is designed to explore the role and mechanism of exosomal circTAOK1 on the glomerular mesangial cell (GMC) injury in DN. Methods Exosomes were detected by a transmission electron microscope. The protein levels of CD9, CD63, proliferating cell nuclear antigen (PCNA), cyclinD1, α-SMA, fibronectin, E-cadherin, N-cadherin, and SMAD family member 3 (SMAD3) were examined by western blot assay. circTAOK1, microRNA-520h (miR-520h), and SMAD3 levels were detected by real-time quantitative polymerase chain reaction (RT-qPCR). Cell proliferation and cell cycle progression were detected by cell counting kit-8 (CCK-8), 5-ethynyl-2′-deoxyuridine (EdU), and flow cytometry assays. The binding relationship between miR-520h and circTAOK1 or SMAD3 was predicted by Starbase and then verified by a dual-luciferase reporter and RNA immunoprecipitation (RIP), RNA pull-down assays. Results CircTAOK1 expression was upregulated in the exosomes isolated from HG-treated glomerular epithelial cells (GEC). Moreover, GEC-circTAOK1-Exo could promote proliferation, fibrosis, and epithelial–mesenchymal transition (EMT) of glomerular mesangial cells (GMCs). Mechanically, circTAOK1 could regulate SMAD3 expression by sponging miR-520h, GEO-si-circTAOK1 Exo-induced miR-520h and repressed SMAD3 expression in GMC. Conclusion GEC-circTAOK1-Exo could boost proliferation, fibrosis, and EMT of GMC through targeting the miR-520h/SMAD3 axis, providing new insights into the pathogenesis of DN.
- 10 February 2022
- Published by Springer Nature in International Urology and Nephrology
- Vol. 54 (9) , 2343-2354
Exosomal circTAOK1 contributes to diabetic kidney disease progression through regulating SMAD3 expression by sponging miR-520h
Background Diabetic nephropathy (DN) is a frequent diabetes complication with complex pathogenesis. Circular RNA (circRNA) circTAOK1 (also named circ_0003928) has been reported to be upregulated in high glucose (HG)-treated human umbilical vein endothelial cells. Also, exosomal circRNAs can exert significant roles in the pathology of various diseases. This study is designed to explore the role and mechanism of exosomal circTAOK1 on the glomerular mesangial cell (GMC) injury in DN. Methods Exosomes were detected by a transmission electron microscope. The protein levels of CD9, CD63, proliferating cell nuclear antigen (PCNA), cyclinD1, α-SMA, fibronectin, E-cadherin, N-cadherin, and SMAD family member 3 (SMAD3) were examined by western blot assay. circTAOK1, microRNA-520h (miR-520h), and SMAD3 levels were detected by real-time quantitative polymerase chain reaction (RT-qPCR). Cell proliferation and cell cycle progression were detected by cell counting kit-8 (CCK-8), 5-ethynyl-2′-deoxyuridine (EdU), and flow cytometry assays. The binding relationship between miR-520h and circTAOK1 or SMAD3 was predicted by Starbase and then verified by a dual-luciferase reporter and RNA immunoprecipitation (RIP), RNA pull-down assays. Results CircTAOK1 expression was upregulated in the exosomes isolated from HG-treated glomerular epithelial cells (GEC). Moreover, GEC-circTAOK1-Exo could promote proliferation, fibrosis, and epithelial–mesenchymal transition (EMT) of glomerular mesangial cells (GMCs). Mechanically, circTAOK1 could regulate SMAD3 expression by sponging miR-520h, GEO-si-circTAOK1 Exo-induced miR-520h and repressed SMAD3 expression in GMC. Conclusion GEC-circTAOK1-Exo could boost proliferation, fibrosis, and EMT of GMC through targeting the miR-520h/SMAD3 axis, providing new insights into the pathogenesis of DN.